Ikarian Capital’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.2M | Hold |
601,703
| – | – | 0.23% | 53 |
|
|
2025
Q1 | $1.5M | Buy |
601,703
+524,087
| +675% | +$1.31M | 0.19% | 50 |
|
|
2024
Q4 | $229K | Buy |
+77,616
| New | +$229K | 0.03% | 101 |
|
|
2023
Q4 | – | Sell |
-229,100
| Closed | -$1.2M | – | 124 |
|
|
2023
Q3 | $1.2M | Buy |
+229,100
| New | +$1.2M | 0.14% | 44 |
|
|
2022
Q2 | – | Sell |
-17,040
| Closed | -$633K | – | 162 |
|
|
2022
Q1 | $633K | Buy |
17,040
+1,184
| +7% | +$44K | 0.08% | 81 |
|
|
2021
Q4 | $927K | Sell |
15,856
-4,167
| -21% | -$244K | 0.14% | 73 |
|
|
2021
Q3 | $1.65M | Sell |
20,023
-10,529
| -34% | -$866K | 0.12% | 75 |
|
|
2021
Q2 | $2.89M | Sell |
30,552
-65,646
| -68% | -$6.2M | 0.23% | 58 |
|
|
2021
Q1 | $6.15M | Sell |
96,198
-53,334
| -36% | -$3.41M | 0.21% | 35 |
|
|
2020
Q4 | $8.7M | Buy |
+149,532
| New | +$8.7M | 0.38% | 20 |
|